Skip to content

Effectiveness of Darvyadi Kwath and Nishamlaki Churna in Diabetes Mellitus

A comparative study to evaluate the effectiveness of â??Darvyadi Kwatha and Nishamalaki Churna�? in management of Madhumeha (Type-2 Diabetes)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042107
Enrollment
82
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION. 2. FBS-126-250mg/dl 3. PPBS 180-400mg/dl 4. HbA1c 6.4 % and more. 5.Patient is taking anti oral diabetic medicine sulphonylureas dosage (glipizide not more then 20mg, glimipride not more then 8mg, glidazidie not more than 180 mg, pioglitazoe not more than 20 mg ) and bigunoids (metformin not more than 1000 mg) 6. Diagnosed case of Diabetes mellitus at least 6 month back

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 21 years and more than the age of 60 years. 2. Fasting Blood Sugar Level >250 mg/dl • 3. Post Prandial Blood Sugar Level >400 mg/dl 4. HbA1c >10% 5. Patients depending on the insulin for blood glucose control. 6. Patients with diabetic complications. 7. Patients suffering from Secondary Diabetes. 8. Gestational diabetes. 9. Pregnant ladies and lactating mothers. 10. Patient is taking any other oral anti diabetic medicine or combination of any oral anti diabetic medicine.

Design outcomes

Primary

MeasureTime frame
Reduction in the value of FBS, Glucose in urine and HBA1CTimepoint: Day1, Day28, Day56, Day84

Secondary

MeasureTime frame
Improvement in graded symptom of Dhatusamyata andVikaropshama MadhumehaTimepoint: Day1, Day28, Day56, Day84

Countries

India

Contacts

Public ContactDr Yogesh Kumar Pandey

Chaudhary Brahm Prakash Ayurved Charak Sansthan

negisonam1234@gmail.com9756998412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026